Variable | Odds ratios (95% CI) | P value |
---|---|---|
All patients ( n = 725)a | ||
Time to antimicrobial therapy >1 hourb | 0.81 (0.54 to 1.23) | 0.323 |
Initial SOFA scorec | 1.19 (1.13 to 1.26) | <0.001 |
Aged | 1.04 (1.03 o 1.06) | <0.001 |
Maximum lactate (day 1)e | 1.09 (1.04 to 1.14) | <0.001 |
Intra-abdominal focus | 1.08 (0.75 to 1.57) | 0.670 |
Urogenital focus | 0.65 (0.36 to 1.14) | 0.143 |
Unknown focus | 1.26 (0.57 to 2.78) | 0.574 |
Community-acquired infection | 0.89 (0.65 to 1.22) | 0.484 |
Inadequate empiric antimicrobial therapy | 1.44 (1.05 to 1.99) | 0.026 |
No de-escalation of antimicrobials within 5 days | 1.17 (0.66 to 2.14) | 0.597 |
Surgical source control required ( n = 234)f | ||
Time to antimicrobial therapy >1 hourb | 0.80 (0.38 to 1.72) | 0.552 |
Initial SOFA scorec | 1.19 (1.08 to 1.31) | <0.001 |
Aged | 1.06 (1.03 to 1.08) | <0.001 |
Maximum lactate (day 1)e | 1.08 (1.00 to 1.13) | 0.046 |
Time to source control >6 hours | 2.36 (1.22 to 4.71) | 0.012 |
Intra-abdominal focus | 1.08 (0.54 to 2.18) | 0.822 |
Urogenital focus | 0.43 (0.12 to 1.34) | 0.165 |
Unknown focusg | – | – |
Community-acquired infection | 1.08 (0.58 to 2.04) | 0.800 |
Inadequate empiric antimicrobial therapy | 1.17 (0.61 to 2.24) | 0.646 |
No de-escalation of antimicrobials within 5 days | 0.94 (0.33 to 2.81) | 0.909 |
No surgical source control required ( n = 424)h | ||
Time to antimicrobial therapy >1 hourb | 0.69 (0.39 to 1.21) | 0.189 |
Initial SOFA scorec | 1.19 (1.11 to 1.28) | <0.001 |
Aged | 1.04 (1.02 to 1.06) | <0.001 |
Maximum lactate (day 1)e | 1.12 (1.05 to 1.20) | 0.001 |
Intra-abdominal focus | 1.72 (0.93 to 3.19) | 0.083 |
Urogenital focus | 0.95 (0.47 to 1.86) | 0.875 |
Unknown focus | 1.67 (0.70 to 3.98) | 0.243 |
Community-acquired infection | 1.03 (0.64 to 1.65) | 0.904 |
Inadequate empiric antimicrobial therapy | 1.52 (0.95 to 2.42) | 0.078 |
No de-escalation of antimicrobials within 5 days | 2.71 (1.02 to 8.40) | 0.061 |